markers. So far no major insurers have told Vermillion that they will cover the cost of OVA1. Neither Aetna Inc. nor Cigna Corp. currently cover the test, but both say they may reconsider once further evidence becomes available. Wellpoint Inc. says it is...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to New Ovarian-Cancer Test
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account